SCHEMBL31728862

SCHEMBL31728862

CCO[C@@H]1COC[C@@H]1Oc1ncc(-c2ccc(F)c(Cl)c2F)c2ncnc(N)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31727993 1.00 — —
SCHEMBL31729294 0.87 EPHA2 (0.31) —
SCHEMBL31728432 0.85 ERBB2 (0.30) —
SCHEMBL31728366 0.85 ERBB2 (0.30) —
SCHEMBL31727792 0.78 PDCD1LG2 (0.36) —
SCHEMBL31729231 0.73 EPHA2 (0.31) —
SCHEMBL31728618 0.71 CLK1 (0.36) —
SCHEMBL31728973 0.68 ERBB2 (0.34) —
SCHEMBL31728213 0.68 EIF2AK3 (0.38) —
SCHEMBL31729163 0.66 CLK1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback